Pharmaceutical potential of red clover (Trifolium pratense L.)
- Authors: Kubasova E.D.1, Krylov I.A.1, Kubasov R.V.1, Sukhanov A.E.1, Nezgovorov D.V.1, Korobitsyn A.P.1, Groshilin V.S.2, Safronenko A.V.2, Dergousova T.G.2, Groshilin S.M.2, Linchenko S.N.3
-
Affiliations:
- Northern State Medical University
- Rostov State Medical University
- Kuban State Medical University
- Issue: Vol 31, No 3 (2024)
- Pages: 179-190
- Section: REVIEWS
- URL: https://journals.rcsi.science/1728-0869/article/view/316090
- DOI: https://doi.org/10.17816/humeco634190
- ID: 316090
Cite item
Full Text
Abstract
BACKGROUND: The development and approval of plant-derived branded drugs have emerged as promising areas in the pharmaceutical industry. Red clover (Trifolium pratense L.) has historically been used in folk medicine as a source of biologically active substances with medicinal properties. Red clover is a widely abundant and easily extractable plant, offering a high cost-efficiency. Therefore, red clover extracts may reasonably be proposed as a potential source for the development of new promising pharmaceuticals.
AIM: To evaluate the pharmaceutical potential of biologically active extracts of red clover.
MATERIAL AND METHODS: The study involved a systematic review of scientific literature sourced from the PubMed biomedical database. A review of the literature was conducted over a 50-year period. The preliminary keyword-based search yielded 1,194 articles. Of these, 41 publications were selected for further analysis, as they were deemed to be the most relevant to the subject matter of the study.
RESULTS: Red clover (Trifolium pratense L.) is a widespread, perennial officinal herb. Herbal extracts have been demonstrated to have a wide range of biological activities. The majority of these compounds are isoflavones, flavonoids, saponins, clovamides, and phenolic acids. Isoflavones are phytoestrogens that have demonstrated efficacy in the treatment of female reproductive system diseases. Moreover, scientific studies have evidenced their anti-inflammatory and reparative potential, along with efficacy in the prevention and treatment of metabolic disorders. Flavonoids, saponins, clovamides, and phenolic acids have been documented to produce antioxidant and antiplatelet effects.
CONCLUSION: Among biologically active extracts of red clover, isoflavones have been identified as the most promising for pharmacological applications. Furthermore, there are other compounds with a well-documented therapeutic potential that require further investigation to develop novel branded drugs.
Full Text
##article.viewOnOriginalSite##About the authors
Elena D. Kubasova
Northern State Medical University
Author for correspondence.
Email: lapkino@mail.ru
ORCID iD: 0000-0001-9683-7814
SPIN-code: 7684-8140
Cand. Sci. (Biology), Associate Professor
Russian Federation, ArkhangelskIlya A. Krylov
Northern State Medical University
Email: krylov.ilya@mail.ru
ORCID iD: 0000-0003-3042-4229
SPIN-code: 1297-5590
MD, Dr. Sci. (Medicine), Associate Professor
Russian Federation, ArkhangelskRoman V. Kubasov
Northern State Medical University
Email: romanas2001@gmail.com
ORCID iD: 0000-0003-1698-6479
SPIN-code: 8780-4464
Cand. Sci. (Biology), Associate Professor
Russian Federation, ArkhangelskAnton E. Sukhanov
Northern State Medical University
Email: docpharmanton@hotmail.com
ORCID iD: 0000-0002-6214-307X
SPIN-code: 7111-5243
MD, Cand. Sci. (Medicine), Associate Professor
Russian Federation, ArkhangelskDmitry V. Nezgovorov
Northern State Medical University
Email: konan192@mail.ru
ORCID iD: 0000-0002-4909-5325
SPIN-code: 1417-1144
Cand. Sci. (Biology), Associate Professor
Russian Federation, ArkhangelskAlexey P. Korobitsyn
Northern State Medical University
Email: alkor@mail.ru
ORCID iD: 0000-0003-4078-4850
SPIN-code: 4097-5036
MD, Cand. Sci. (Medicine)
Russian Federation, ArkhangelskVitaly S. Groshilin
Rostov State Medical University
Email: groshilin@yandex.ru
ORCID iD: 0000-0001-9927-8798
SPIN-code: 8717-0391
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Rostov-on-DonAndrey V. Safronenko
Rostov State Medical University
Email: andrejsaf@mail.ru
ORCID iD: 0000-0003-4625-6186
SPIN-code: 3448-9574
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Rostov-on-DonTatyana G. Dergousova
Rostov State Medical University
Email: Tatyana-701@yandex.ru
ORCID iD: 0000-0001-6334-1169
SPIN-code: 9900-8949
Cand. Sci. (Pharmacy), Associate Professor
Russian Federation, Rostov-on-DonSergey M. Groshilin
Rostov State Medical University
Email: 9185546646@rambler.ru
ORCID iD: 0000-0003-2782-7094
SPIN-code: 3980-0099
MD, Dr. Sci. (Medicine), Professor
Russian Federation, Rostov-on-DonSergey N. Linchenko
Kuban State Medical University
Email: s_linchenko@mail.ru
ORCID iD: 0000-0001-8345-0645
SPIN-code: 1681-3350
MD, Dr. Sci. (Medicine), Professor
Russian Federation, KrasnodarReferences
- Marrelli M. Medicinal plants. Plants (Basel). 2021;10(7):1355. doi: 10.3390/plants10071355
- Šantić Ž, Pravdić N, Bevanda M, Galić K. The historical use of medicinal plants in traditional and scientific medicine. Psychiatr Danub. 2017;29(Suppl 4):787–792.
- Les F, Cásedas G, López V. Bioactivity of medicinal plants and extracts. Biology (Basel). 2021;10(7):634. doi: 10.3390/biology10070634
- Silveira D, Boylan F. Medicinal plants: advances in phytochemistry and ethnobotany. Plants (Basel). 2023;12(8):1682. doi: 10.3390/plants12081682
- Rogozea L. Medicinal plants usage in our days. Am J Ther. 2018;25(4):e487–e488. doi: 10.1097/MJT.0000000000000795
- van Galen E. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe. J Ethnopharmacol. 2014;158 Pt B:498–502. doi: 10.1016/j.jep.2014.07.013
- Sabudak T, Guler N. Trifolium L. — a review on its phytochemical and pharmacological profile. Phytother Res. 2009;23(3):439–446. doi: 10.1002/ptr.2709
- Kolodziejczyk-Czepas J. Trifolium species-derived substances and extracts-biological activity and prospects for medicinal applications. J Ethnopharmacol. 2012;143(1):14–23. doi: 10.1016/j.jep.2012.06.048
- Zhang H, Zhao J, Shang H, et al. Extraction, purification, hypoglycemic and antioxidant activities of red clover (Trifolium pratense L.) polysaccharides. Int J Biol Macromol. 2020;148:750–760. doi: 10.1016/j.ijbiomac.2020.01.194
- Kaurinovic B, Popovic M, Vlaisavljevic S, et al. Antioxidant profile of Trifolium pratense L. Molecules. 2012;17(9):11156–11172. doi: 10.3390/molecules170911156
- Krenn L, Paper DH. Inhibition of angiogenesis and inflammation by an extract of red clover (Trifolium pratense L.). Phytomedicine. 2009;16(12):1083–1088. doi: 10.1016/j.phymed.2009.05.017
- Gounden T, Moodley R, Jonnalagadda SB. Elemental analysis and nutritional value of edible Trifolium (clover) species. J Environ Sci Health B. 2018;53(8):487–492. doi: 10.1080/03601234.2018.1462923
- Malca-Garcia GR, Zagal D, Graham J, et al. Dynamics of the isoflavone metabolome of traditional preparations of Trifolium pratense L. J Ethnopharmacol. 2019;238:111865. doi: 10.1016/j.jep.2019.111865
- Vlaisavljevic S, Kaurinovic B, Popovic M, et al. Trifolium pratense L. as a potential natural antioxidant. Molecules. 2014;19(1):713–725. doi: 10.3390/molecules19010713
- Myers SP, Vigar V. Effects of a standardised extract of Trifolium pratense (Promensil) at a dosage of 80mg in the treatment of menopausal hot flushes: A systematic review and meta-analysis. Phytomedicine. 2017;24:141–147. doi: 10.1016/j.phymed.2016.12.003
- Gartoulla P, Han MM. Red clover extract for alleviating hot flushes in postmenopausal women: a meta-analysis. Maturitas. 2014;79(1):58–64. doi: 10.1016/j.maturitas.2014.06.018
- Kolodziejczyk-Czepas J, Wachowicz B, Moniuszko-Szajwaj B, et al. Antioxidative effects of extracts from Trifolium species on blood platelets exposed to oxidative stress. J Physiol Biochem. 2013;69(4):879–887. doi: 10.1007/s13105-013-0264-5
- Renda G, Yalçın FN, Nemutlu E, et al. Comparative assessment of dermal wound healing potentials of various Trifolium L. extracts and determination of their isoflavone contents as potential active ingredients. J Ethnopharmacol. 2013;148(2):423–432. doi: 10.1016/j.jep.2013.04.031
- Manzoureh R, Farahpour MR. Topical administration of hydroethanolic extract of Trifolium pratense (red clover) accelerates wound healing by apoptosis and re-epithelialization. Biotech Histochem. 2021;96(4):276–286. doi: 10.1080/10520295.2020.1797875
- Antonescu Mintas AI, Miere Groza F, Fritea L, et al. Perspectives on the combined effects of ocimum basilicum and trifolium pratense extracts in terms of phytochemical profile and pharmacological effects. Plants (Basel). 2021;10(7):1390. doi: 10.3390/plants10071390
- Khazaei MR, Pazhouhi M. Antiproliferative effect of Trifolium Pratens L. extract in human breast cancer cells. Nutr Cancer. 2019;71(1):128–140. doi: 10.1080/01635581.2018.1521443
- Tanrıverdi G, Abdulova A, Çölgeçen H, et al. Investigation of apoptotic and antiproliferative effects of Turkish natural tetraploids Trifolium pratense L. extract on C6 glioblastoma cells via light and electron microscopy. Ultrastruct Pathol. 2023;47(3):160–171. doi: 10.1080/01913123.2023.2184893
- Zakłos-Szyda M, Budryn G. The effects of Trifolium pratense L. Sprouts’ phenolic compounds on cell growth and migration of MDA-MB-231, MCF-7 and HUVEC cells. Nutrients. 2020;12(1):257. doi: 10.3390/nu12010257
- Khazaei MR, Gravandi E, Ghanbari E, et al. Trifolium pratense extract increases testosterone and improves sperm characteristics and antioxidant status in diabetic rats. Biotech Histochem. 2022;97(8):576–583. doi: 10.1080/10520295.2022.2039766
- Błaszczuk A, Barańska A, Kanadys W, et al. Role of phytoestrogen-rich bioactive substances (Linum usitatissimum L., Glycine max L., Trifolium pratense L.) in cardiovascular disease prevention in postmenopausal women: a systematic review and meta-analysis. Nutrients. 2022;14(12):2467. doi: 10.3390/nu14122467
- Quah Y, Park NH, Lee EB, et al. Trifolium pratense ethanolic extract alters the gut microbiota composition and regulates serum lipid profile in the ovariectomized rats. BMC Complement Med Ther. 2022;22(1):5. doi: 10.1186/s12906-021-03486-w
- Pakalapati G, Li L, Gretz N, et al. Influence of red clover (Trifolium pratense) isoflavones on gene and protein expression profiles in liver of ovariectomized rats. Phytomedicine. 2009;16(9):845–855. doi: 10.1016/j.phymed.2009.03.003
- Oza MJ, Kulkarni YA. Trifolium pratense (red clover) improve SIRT1 expression and glycogen content in high fat diet-streptozotocin induced type 2 diabetes in rats. Chem Biodivers. 2020;17(4):e2000019. doi: 10.1002/cbdv.202000019
- Lee SA, Park BR, Moon SM, et al. Anti-inflammatory potential of Trifolium pratense L. leaf extract in LPS-stimulated RAW264.7 cells and in a rat model of carrageenan-induced inflammation. Arch Physiol Biochem. 2020;126(1):74–81. doi: 10.1080/13813455.2018.1493607
- Lee SG, Brownmiller CR, Lee SO, Kang HW. Anti-inflammatory and antioxidant effects of anthocyanins of Trifolium pratense (red clover) in lipopolysaccharide-stimulated RAW-267.4 macrophages. Nutrients. 2020;12(4):1089. doi: 10.3390/nu12041089
- Al-Shami AS, Essawy AE, Elkader HE. Molecular mechanisms underlying the potential neuroprotective effects of Trifolium pratense and its phytoestrogen-isoflavones in neurodegenerative disorders. Phytother Res. 2023;37(6):2693–2737. doi: 10.1002/ptr.7870
- de Rus Jacquet A, Ambaw A, Tambe MA, et al. Neuroprotective mechanisms of red clover and soy isoflavones in Parkinson’s disease models. Food Funct. 2021;12(23):11987–12007. doi: 10.1039/d1fo00007a
- Occhiuto F, Palumbo DR, Samperi S, et al. The isoflavones mixture from Trifolium pratense L. protects HCN 1-A neurons from oxidative stress. Phytother Res. 2009;23(2):192–196. doi: 10.1002/ptr.2584
- Jiang D, Rasul A, Batool R, et al. Potential anticancer properties and mechanisms of action of Formononetin. Biomed Res Int. 2019;2019:5854315. doi: 10.1155/2019/5854315
- Mu H, Bai YH, Wang ST, et al. Research on antioxidant effects and estrogenic effects of formononetin from Trifolium pratense (red clover). Phytomedicine. 2009;16(4):314–319. doi: 10.1016/j.phymed.2008.07.005
- Kolodziejczyk-Czepas J. Trifolium species — the latest findings on chemical profile, ethnomedicinal use and pharmacological properties. J Pharm Pharmacol. 2016;68(7):845–861. doi: 10.1111/jphp.12568
- Kolodziejczyk-Czepas J, Krzyżanowska-Kowalczyk J, Sieradzka M, et al. Clovamide and clovamide-rich extracts of three Trifolium species as antioxidants and moderate antiplatelet agents in vitro. Phytochemistry. 2017;143:54–63. doi: 10.1016/j.phytochem.2017.07.011
- Yan J, Qiu P, Zhang X, et al. Biochanin A from chinese medicine: an isoflavone with diverse pharmacological properties. Am J Chin Med. 2021;49(7):1623–1643. doi: 10.1142/S0192415X21500750
- Fokialakis N, Alexi X, Aligiannis N, et al. Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities. Bioorg Med Chem. 2012;20(9):2962–2970. doi: 10.1016/j.bmc.2012.03.012
- Lin VC, Ding HY, Tsai PC, et al. In vitro and in vivo melanogenesis inhibition by biochanin A from Trifolium pratense. Biosci Biotechnol Biochem. 2011;75(5):914–918. doi: 10.1271/bbb.100878
- Lee JH, Dean M, Austin JR, et al. Irilone from red clover (Trifolium pratense) potentiates progesterone signaling. J Nat Prod. 2018;81(9):1962–1967. doi: 10.1021/acs.jnatprod.8b00131
Supplementary files
